Prostate cancer is one of the most common malignant tumors. It ranks first or second among the causes of death from cancer in men.
Prostate cancer is a significant global health concern that requires urgent attention, similar to breast cancer. It affects a large number of individuals worldwide and presents a pressing challenge for public health.
At an early stage, prostate cancer has no symptoms, it is asymptomatic, so it can be detected only with a comprehensive study. However, it should be noted that in the early stages, the symptoms of this cancer are not much different from the complaints of a normal adenoma, and the patient may experience, for example, frequent urination, the nighttime urge to urinate, painful urination, decreased urine flow, the feeling of dissatisfaction after urination and others.
Today, modern advancements in global medicine have significantly improved the reliability, accuracy, comfort, affordability, and effectiveness of early diagnosis and treatment of this gland’s cancer.
In Georgia, in particular, in the MMT hospital, such diagnostic tools are already available that detect prostate cancer with 100% accuracy, even at an early, asymptomatic stage.
Since 2021, the MMT hospital in Georgia has been the only hospital in the region, capable of detecting prostate cancer with 100% accuracy, even in its early asymptomatic stage.
Such means are:
- Micro-ultrasound of the prostate using high-resolution micro-ultrasound – ExactVu. State-of-the-art technology that provides a 300% increase in visualization of suspicious areas of the prostate.
- Targeted biopsy guided by Micro-ultrasound, one of the state-of-the-art targeted biopsies that avoids blind and unnecessary biopsies, is performed using the ExactVu micro-ultrasonic device – a fast and painless procedure that guarantees the most accurate diagnosis!
- Biopsy “Fusion” with simultaneous control of magnetic resonance (MRI) and micro-ultrasound – fusion of micro-ultrasound and MRI data provides the highest level of visualization and resolution, the most accurate targeting of the suspicious area is carried out, biopsy is performed in real-time and cancer is detected in 100% of cases.
- And most importantly, a revolutionary innovation in the treatment of early-stage prostate cancer – Focal One Ruth, ie. robotic ultrasound therapy, which, without radiation or surgery, destroys the tumor in just a few hours without surgical intervention and preserves the healthy tissues of the patient and the prostate – respectively, the quality of life, since by preserving the prostate, the patient maintains normal sexual and urinary functions. This is an innovative advantage that is unmatched by any other prostate cancer treatment and is extremely important for the patient.